Impact of ETI Therapy on CFTR Function in N1303K Variant Patients
Pubblicato da：Unknown
·Pubblicato il: 2025-12-13
Discussion regarding the effectiveness of the triple combination therapy Elexacaftor+Tezacaftor+Ivacaftor (ETI) in restoring CFTR function specifically for Cystic Fibrosis patients with the N1303K variant.
Caricamento...